Physician profile
Patrick A Bowen
NPI 1003137589
$1,143.79
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.33 · 2022: $218 · 2023: $323 · 2024: $335 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $314.01 | 2021-2023 | |
| Glaxosmithkline, LLC. | $123.03 | 2021-2025 | Bexsero, Pediarix, Penmenvy |
| Pfizer INC. | $116.45 | 2022-2025 | |
| Corium, LLC | $104.31 | 2023-2025 | Azstarys |
| Sanofi Pasteur INC. | $78.00 | 2023-2025 | |
| Ironshore Pharmaceuticals INC. | $60.29 | 2023-2024 | Jornay Pm |
| Cranial Technologies, INC | $52.80 | 2024 | Doc Band |
| Neos Therapeutics, Lp | $42.29 | 2022-2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Supernus Pharmaceuticals, INC. | $35.85 | 2022-2023 | Qelbree |
| Kyowa Kirin, INC. | $33.19 | 2024-2025 | Crysvita |
| Tris Pharma INC | $29.69 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.07 | 2024-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $27.73 | 2024 | |
| Collegium Pharmaceutical, INC. | $23.56 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $15.75 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.95 | 2024 | Xolair |
| Ars Pharmaceuticals Operations, INC. | $14.86 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $14.18 | 2023 | Gardasil 9 |
| Kaleo, INC. | $13.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.